<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00202358</url>
  </required_header>
  <id_info>
    <org_study_id>PEACK</org_study_id>
    <nct_id>NCT00202358</nct_id>
  </id_info>
  <brief_title>Perioperative Effect of Atenolol on Cytokine Profiles</brief_title>
  <official_title>The Effect of Perioperative Atenolol on Post-Operative Cytokines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saini Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Saini Foundation</source>
  <brief_summary>
    <textblock>
      Studies have shown that beta-blockers such as atenolol when given in the perioperative period
      reduce morbidity and mortality. One study showed that atenolol given just during the surgery
      period, seemed to improve outcomes up to 2 years later. This is hard to explain since
      beta-blockers act on the body by blocking the effects of adrenalin and thereby lowering heart
      rate and blood pressure.

      This study is designed to find out if perioperative atenolol might exert its long term
      effects through an anti-inflammatory mechanism rather than by lowering heart rate and blood
      pressure. It is known that inflammation increases after surgery as part of the healing
      process. However, it is also becoming clear that low-grade chronic inflammation can also lead
      to long term adverse effects.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2002</start_date>
  <completion_date type="Anticipated">September 2008</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative levels of IL-6 and C-Reactive protein</measure>
    <time_frame>6 hrs, 48 hrs, 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>IL-10, TNF-Î±</measure>
    <time_frame>6 hrs, 48 hrs, 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>atenolol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>atenolol</intervention_name>
    <arm_group_label>atenolol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective abdominal, orthopedic, or gynecologic surgery

          -  ability to give informed consent

          -  ability to tolerate beta-blocker therapy

          -  ability to comply with follow-up requirements

        Exclusion Criteria:

          -  currently receiving beta-blocker therapy

          -  EKG documented 2nd or 3rd degree heart block

          -  EKG documented sinus bradycardia

          -  Serum creatinine &gt; 2.0

          -  current treatment asthma

          -  history of rheumatoid arthritis

          -  history of Crohn's disease

          -  history of lupus

          -  history of inflammatory cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vikas Saini, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept Medicine, Cape Cod Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cape Cod Hospital</name>
      <address>
        <city>Hyannis</city>
        <state>Massachusetts</state>
        <zip>02601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>June 13, 2008</last_update_submitted>
  <last_update_submitted_qc>June 13, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2008</last_update_posted>
  <responsible_party>
    <name_title>Vikas Saini, M.D.</name_title>
    <organization>Cape Cod Hospital</organization>
  </responsible_party>
  <keyword>perioperative</keyword>
  <keyword>beta-blockers</keyword>
  <keyword>inflammation</keyword>
  <keyword>outcomes</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atenolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

